<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Boston Commerce Ltd. (BOSTON BIO) — Tipsheet</title>
    <link>https://tipsheet.markets/company/boston%20bio/</link>
    <atom:link href="https://tipsheet.markets/company/boston%20bio/feed.xml" rel="self" type="application/rss+xml" />
    <description>Every Tipsheet Editorial note covering Boston Commerce Ltd. (BOSTON BIO), newest first. Grounded in BSE/NSE primary-source filings.</description>
    <language>en-in</language>
    <lastBuildDate>Tue, 28 Jul 2026 14:38:33 GMT</lastBuildDate>
    <item>
      <title>Boston Commerce cancels 95% of equity to wipe out losses</title>
      <link>https://tipsheet.markets/boston-bio-boston-commerce-cancels-95-of-equity-to-wipe-out-losses-119923/</link>
      <guid isPermaLink="true">https://tipsheet.markets/boston-bio-boston-commerce-cancels-95-of-equity-to-wipe-out-losses-119923/</guid>
      <pubDate>Tue, 07 Jul 2026 19:44:01 GMT</pubDate>
      <description>The nano-cap&#39;s board approved a scheme that shrinks paid-up capital from ₹7 cr to ₹35 lakh, with no payout to shareholders. The move sets up a cleaner balance sheet but doesn&#39;t fix the underlying business.</description>
      <content:encoded><![CDATA[<p><em>The nano-cap's board approved a scheme that shrinks paid-up capital from ₹7 cr to ₹35 lakh, with no payout to shareholders. The move sets up a cleaner balance sheet but doesn't fix the underlying business.</em></p>
<h3>What’s new</h3><ul><li>Board approved cancellation of 66.52 lakh shares, reducing capital to ₹35 lakh.</li><li>No cash compensation for cancelled shares; proceeds used to offset accumulated losses.</li><li>New statutory and secretarial auditors appointed; fundraising and promoter reclassification postponed.</li></ul>
<h3>Why it matters</h3><p>For a company with negative net worth and a going-concern audit, a 95% capital reduction is a drastic but necessary balance-sheet cleanup. It removes the accumulated loss overhang but does nothing for operations, as the company reported zero revenue in the latest quarter.</p>
<h3>What we’re watching</h3><ul><li>Shareholder vote at EGM on 5 August, likely to pass given promoter control.</li><li>Whether the company proceeds with its planned ₹100 crore annual fundraising after this cleanup.</li><li>If the auditor removes the going-concern qualification after the capital reduction.</li></ul>
<h3>The full read</h3><p>Boston Commerce's board has approved a capital reduction scheme that cancels <strong>66.52 lakh shares</strong> (a <strong>95%</strong> reduction) cutting paid-up capital from <strong>₹7 crore</strong> to <strong>₹35 lakh</strong>. No cash goes to shareholders. The purpose is to write off accumulated losses that have left the company with negative net worth of <strong>₹1.27 crore</strong> and a going-concern flag from its auditor. For a nano-cap worth <strong>₹4 crore</strong> that reported <strong>zero sales</strong> last quarter, this is a dramatic balance-sheet cleanup. It is also the first concrete step since the company outlined plans to raise <strong>₹100 crore annually</strong>. The scheme needs shareholder approval at an <strong>EGM on 5 August</strong>. It will not revive topline overnight, but it removes the accumulated loss overhang, a necessary condition for any future turnaround.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=531458&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=BOSTON%20BIO">NSE</a></p>]]></content:encoded>
      <category>Other</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>Boston Commerce, worth ₹4 cr, plans to raise ₹100 cr a year</title>
      <link>https://tipsheet.markets/boston-bio-boston-commerce-worth-4-cr-plans-to-raise-100-cr-a-year-118398/</link>
      <guid isPermaLink="true">https://tipsheet.markets/boston-bio-boston-commerce-worth-4-cr-plans-to-raise-100-cr-a-year-118398/</guid>
      <pubDate>Thu, 02 Jul 2026 15:38:39 GMT</pubDate>
      <description>Nano-cap with negative net worth and a going-concern warning will vote on fundraising, promoter reclassification, and capital reduction, all at a scale several thousand percent of its market cap.</description>
      <content:encoded><![CDATA[<p><em>Nano-cap with negative net worth and a going-concern warning will vote on fundraising, promoter reclassification, and capital reduction, all at a scale several thousand percent of its market cap.</em></p>
<h3>What’s new</h3><ul><li>Board to consider raising up to ₹100 cr each year via equity, warrants or private placements through FY28-29.</li><li>Also on the agenda: promoter reclassification to public category, capital reduction, and disposal of non-core assets.</li><li>Proposals come days after auditor flagged negative net worth of ₹1.27 cr and going-concern uncertainty.</li></ul>
<h3>Why it matters</h3><p>For a company with a market cap of just ₹4 cr and trailing negative equity, a plan to raise ₹100 cr annually is an order-of-magnitude event. If approved, existing shareholders face extreme dilution or a complete business transformation. The promoter reclassification adds the possibility of a control change.</p>
<h3>What we’re watching</h3><ul><li>Whether the board approves the proposals on 7 July 2026.</li><li>Any disclosure on the rationale behind the massive scale of fundraising.</li><li>Auditor's reaction to the capital reduction and asset disposal plans.</li></ul>
<h3>The full read</h3><p>Boston Commerce has a market cap of <strong>₹4 crore</strong>, negative net worth of <strong>₹1.27 crore</strong>, and an auditor that just flagged a going-concern risk. Now its board will meet on 7 July to consider raising <strong>₹100 crore each year</strong> through FY28-29, an amount <strong>25 times</strong> its entire equity value. The agenda also includes promoter reclassification, capital reduction, and asset disposal. These are only proposals, but for a company with zero revenue and a <strong>₹7 crore</strong> quarterly loss, the scale is staggering. If approved, existing holders face either radical dilution or a complete change of control. The board meeting on 7 July will determine the next chapter.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=531458&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=BOSTON%20BIO">NSE</a></p>]]></content:encoded>
      <category>Other</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>Boston Commerce revised filing confirms auditor&#39;s going concern warning</title>
      <link>https://tipsheet.markets/boston-bio-boston-commerce-revised-filing-confirms-auditor-s-going-concern-warning-112192/</link>
      <guid isPermaLink="true">https://tipsheet.markets/boston-bio-boston-commerce-revised-filing-confirms-auditor-s-going-concern-warning-112192/</guid>
      <pubDate>Wed, 24 Jun 2026 15:52:13 GMT</pubDate>
      <description>Assets plunged from ₹1490.37 lakh to ₹76.86 lakh, net worth turns negative at ₹127.15 lakh. Revenue nil, loss of ₹724.11 lakh.</description>
      <content:encoded><![CDATA[<p><em>Assets plunged from ₹1490.37 lakh to ₹76.86 lakh, net worth turns negative at ₹127.15 lakh. Revenue nil, loss of ₹724.11 lakh.</em></p>
<h3>What’s new</h3><ul><li>Revised annual results filed after exchange query confirm qualified audit opinion.</li><li>Auditors flagged missing special resolution for write-offs of untraceable assets and liabilities.</li><li>Material uncertainty about going concern; non-payment of TDS also noted.</li></ul>
<h3>Why it matters</h3><p>This revision adds no new facts to what was already disclosed, but it cements the auditor's stance under regulatory scrutiny. A company with negative net worth, zero revenue, and a ₹724 lakh loss against a ₹4 crore market cap is effectively insolvent.</p>
<h3>What we’re watching</h3><ul><li>Whether SEBI or other regulators take action on the missing shareholder resolution.</li><li>Any restructuring or capital infusion plan from management.</li><li>Trading suspension risk given the going concern flag.</li></ul>
<h3>The full read</h3><p>Boston Commerce's revised annual filing confirms what its auditor already said: the company wrote off nearly its entire asset base without a shareholder vote. Assets dropped from <strong>₹1490.37 lakh</strong> to <strong>₹76.86 lakh</strong>. Net worth turned negative at <strong>₹127.15 lakh</strong>. Revenue for the quarter was nil, and the net loss widened to <strong>₹724.11 lakh</strong> — far exceeding the company's <strong>₹4 crore</strong> market cap. The audit flagged unpaid TDS and a going-concern risk. This revision is a procedural response to an exchange query, not new news. But it formalises a picture of a company that, by any conventional measure, has stopped functioning as a going concern.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=531458&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=BOSTON%20BIO">NSE</a></p>]]></content:encoded>
      <category>Earnings</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>Boston Commerce&#39;s auditor flags going concern after write-offs wipe out assets</title>
      <link>https://tipsheet.markets/boston-bio-boston-commerce-s-auditor-flags-going-concern-after-write-offs-wipe-out-assets-107472/</link>
      <guid isPermaLink="true">https://tipsheet.markets/boston-bio-boston-commerce-s-auditor-flags-going-concern-after-write-offs-wipe-out-assets-107472/</guid>
      <pubDate>Wed, 10 Jun 2026 19:37:10 GMT</pubDate>
      <description>A qualified audit report reveals the auditor initially gave a false clean opinion, which had to be corrected. Virtually all assets are gone, net worth is negative, and shareholders never approved the write-offs.</description>
      <content:encoded><![CDATA[<p><em>A qualified audit report reveals the auditor initially gave a false clean opinion, which had to be corrected. Virtually all assets are gone, net worth is negative, and shareholders never approved the write-offs.</em></p>
<h3>What’s new</h3><ul><li>Statutory auditors issued a qualified opinion on Boston Commerce's FY26 financials, correcting an initially filed false unmodified report.</li><li>A Q4 write-off wiped most assets and liabilities without the required shareholder special resolution.</li><li>Auditors flagged a material uncertainty over the company's ability to continue as a going concern and noted unpaid TDS dues.</li></ul>
<h3>Why it matters</h3><p>The filing is a two-layer governance failure. First, the auditors caught their own mistake: the company filed a clean opinion that was not clean. Second, the substance of the qualification is severe—assets written off without shareholder consent, TDS unpaid, and a negative net worth of ₹1.27 crore against a market cap of just ₹5 crore. For a nano-cap, this eliminates the thin equity cushion it had.</p>
<h3>What we’re watching</h3><ul><li>Whether SEBI or stock exchanges initiate proceedings over the incorrect initial filing.</li><li>How the company plans to meet its liabilities with a ₹1.27 crore net worth deficit.</li><li>The fate of the next audit cycle, given the going-concern qualification.</li></ul>
<h3>The full read</h3><p>Boston Commerce's FY26 audit is a disaster on two fronts. The first is procedural: the company initially filed results with a clean opinion, only for its auditors to later issue a qualified report. The second is existential. The qualification stems from a Q4 write-off that gutted <strong>₹14.9 crore</strong> in assets down to <strong>₹0.77 crore</strong>, leaving a net worth deficit of <strong>₹1.27 crore</strong>. The auditors note the write-off lacked the required shareholder resolution and that the company didn't pay its TDS. Most critically, they have flagged a material uncertainty over whether Boston Commerce can continue as a going concern. For a nano-cap with a <strong>₹5 crore</strong> market cap, a negative net worth means the equity base is gone. The filing itself is now suspect, having been corrected once.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=531458&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=BOSTON%20BIO">NSE</a></p>]]></content:encoded>
      <category>Other</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>Boston Commerce is writing off assets and shrinking its capital</title>
      <link>https://tipsheet.markets/boston-bio-boston-commerce-is-writing-off-assets-and-shrinking-its-capital-106009/</link>
      <guid isPermaLink="true">https://tipsheet.markets/boston-bio-boston-commerce-is-writing-off-assets-and-shrinking-its-capital-106009/</guid>
      <pubDate>Fri, 05 Jun 2026 19:24:37 GMT</pubDate>
      <description>The ₹5 cr nano-cap has started a balance-sheet cleanup. The numbers are not yet available.</description>
      <content:encoded><![CDATA[<p><em>The ₹5 cr nano-cap has started a balance-sheet cleanup. The numbers are not yet available.</em></p>
<h3>What’s new</h3><ul><li>The board has approved a scheme to write off 'not readily realisable' assets.</li><li>A parallel scheme for capital reduction has also been initiated.</li><li>Both plans are under preparation and require shareholder and regulatory approval.</li></ul>
<h3>Why it matters</h3><p>For a loss-making company worth ₹5 crore, scrubbing dead assets and trimming capital are standard hygiene steps. The filing signals management knows the balance sheet needs work. But with no numbers attached to either plan, this remains a statement of intent, not a transaction.</p>
<h3>What we’re watching</h3><ul><li>The eventual size of the asset write-off once the scheme is drafted.</li><li>How much capital the company plans to extinguish.</li><li>Any creditor objections that could delay or block the schemes.</li></ul>
<h3>The full read</h3><p>Boston Commerce, a <strong>₹5.0 crore</strong> market-cap company with a history of losses, is cleaning house. Its board has started drafting plans to write off assets it deems unsellable and to reduce its capital. These are the first steps in a classic balance-sheet reset. The problem is the details: the filing gives no indication of how much in assets will be written off or how much capital will be reduced. Without those numbers, this is a process, not a transaction. Execution also hinges on approvals from shareholders and regulators, neither of which is guaranteed. For now, the signal is that management acknowledges the balance sheet needs work. What it actually looks like after the write-downs is the story. Hardly a catalyst.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=531458&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=BOSTON%20BIO">NSE</a></p>]]></content:encoded>
      <category>Other</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>Boston Commerce&#39;s losses are 44x its market cap. Its auditor flagged unpaid taxes.</title>
      <link>https://tipsheet.markets/boston-bio-boston-commerce-s-losses-are-44x-its-market-cap-its-auditor-flagged-unpaid-taxes-104305/</link>
      <guid isPermaLink="true">https://tipsheet.markets/boston-bio-boston-commerce-s-losses-are-44x-its-market-cap-its-auditor-flagged-unpaid-taxes-104305/</guid>
      <pubDate>Sat, 30 May 2026 18:14:39 GMT</pubDate>
      <description>The nano-cap&#39;s Q4 net loss ballooned to ₹64.58 lakhs. Revenue dropped 60% sequentially. The auditor noted the company failed to pay its TDS dues.</description>
      <content:encoded><![CDATA[<p><em>The nano-cap's Q4 net loss ballooned to ₹64.58 lakhs. Revenue dropped 60% sequentially. The auditor noted the company failed to pay its TDS dues.</em></p>
<h3>What’s new</h3><ul><li>Q4 net loss ballooned to ₹64.58 lakhs, up from just ₹1.44 lakhs in Q3.</li><li>Revenue fell to ₹19.25 lakhs from ₹48.37 lakhs in the prior quarter.</li><li>Auditor flagged non-payment of TDS dues during the year.</li></ul>
<h3>Why it matters</h3><p>A ₹64 lakh quarterly loss is modest for most companies. For a ₹5 crore nano-cap, it is devastating. The unpaid TDS, flagged by the auditor, is a direct indicator that cash is not available to meet even basic statutory obligations.</p>
<h3>What we’re watching</h3><ul><li>Whether the tax authorities follow up on the unpaid TDS dues.</li><li>Any move to raise capital or cut costs to stem the cash bleed.</li><li>The trajectory of revenue, which has now fallen for two straight quarters.</li></ul>
<h3>The full read</h3><p>Boston Commerce's audited FY2026 numbers show a cash problem getting worse. The <strong>₹5 crore</strong> nano-cap posted a Q4 net loss of <strong>₹64.58 lakhs</strong>, up from just <strong>₹1.44 lakhs</strong> in Q3. Revenue dropped to <strong>₹19.25 lakhs</strong> from <strong>₹48.37 lakhs</strong>. The full-year loss widened to <strong>₹58.08 lakhs</strong> from <strong>₹54.73 lakhs</strong> in FY2025. The auditor flagged one governance issue: the company did not pay its TDS dues. The opinion was unmodified, but the tax default is a clear sign that liquidity is strained. For a business of this size, failing to remit taxes to the government is a serious operational red flag. Not yet a crisis for authorities. But a clear signal the cash is gone.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=531458&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=BOSTON%20BIO">NSE</a></p>]]></content:encoded>
      <category>Earnings</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
  </channel>
</rss>